Pediatr Infect Vaccine.  2018 Dec;25(3):165-169. 10.14776/piv.2018.25.e13.

Neonatal Sepsis and Meningitis Caused by Neisseria meningitidis Serogroup B: a Case Report

• Kim YN
• Choi YS
• Cha SH

• KMID: 2428254
• DOI: http://doi.org/10.14776/piv.2018.25.e13

Abstract

Sepsis and meningitis caused by Neisseria meningitidis are rare in neonates, but neonatal sepsis and meningitis are associated with a high rate of mortality. Meningococcal disease is commonly reported in older children and adolescents and is known to be more prevalent in community settings. In this study, a 16-day-old neonate was diagnosed with serogroup B meningococcal sepsis and meningitis. The baby was treated with antibiotics at the early stages of the infection and was discharged in good condition without any complications. This case report can serve to raise awareness of the incidence and importance of meningococcal infection in neonates, especially serogroup B.

Keyword

Meningococcal infections; Neisseria; meningitis

MeSH Terms

Adolescent
Anti-Bacterial Agents
Child
Humans
Incidence
Infant, Newborn
Meningitis*
Meningococcal Infections
Mortality
Neisseria meningitidis*
Neisseria*
Sepsis*
Serogroup*
Anti-Bacterial Agents

Reference

1. Klein J, Marcy S. Bacterial sepsis and meningitis. In : Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia (PA): Saunders;1995. p. 835–890.

2. Kiray Baş E, Bülbül A, Cömert S, Uslu S, Arslan S, Nuhoglu A. Neonatal infection with Neisseria meningitidis: analysis of a 97-year period plus case study. J Clin Microbiol. 2014; 52:3478–3482.

3. World Health Organization. Meningococcal meningitis [Internet]. Geneva: World Health Organization;2015. cited 2017 Dec 12. Available from: http://www.who.int/immunization/diseases/meningitis/en/.

4. Kliegman R, Stanton B, St Geme JW III, Schor NF, Behrman RE. Neisseria meningitidis (Meningococcus). In : Pollard AJ, Sadarangani M, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia (PA): Elsevier Health Sciences;2016. p. 1356–1365.

5. Buckwalter CM, Currie EG, Tsang RS, Gray-Owen SD. Discordant effects of licensed meningococcal serogroup B vaccination on invasive disease and nasal colonization in a humanized mouse model. J Infect Dis. 2017; 215:1590–1598.

6. Memish ZA, Al-Tawfiq JA, Almasri M, Azhar EI, Yasir M, Al-Saeed MS, et al. Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine. 2017; 35:2473–2478.

7. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011; 86:521–539.

8. Bilal A, Taha MK, Caeymaex L, Cohen R, Levy C, Durrmeyer X, et al. Neonatal meningococcal meningitis in France from 2001 to 2013. Pediatr Infect Dis J. 2016; 35:1270–1272.

9. MacNeil JR, Meyer SA. Meningococcal disease [Internet]. Atlanta (GA): Centers for Disease Control and Prevention;2017. cited 2017 Jan 3. Available from: https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/meningococcal-disease.

10. Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016; 388:2775–2782.

11. Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine. 2017; 35:2034–2041.

12. Feavers IM, Maiden MC. Recent progress in the prevention of serogroup B meningococcal disease. Clin Vaccine Immunol. 2017; 24:e00566-16.

13. The Korean Pediatric Society. Neisseria meningitidis vaccine. In : Kim KH, editor. Immunization guideline. 8th ed. Seoul: The Korean Pediatric Society;2015. p. 253–270.

14. Centers for Disease Control and Prevention. Meningococcal disease: risk factors. Atlanta (GA): Centers for Disease Control and Prevention;2017. cited 2018 Jan 3. Available from: https://www.cdc.gov/meningococcal/about/risk-factors.html.